A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants-Reference-Cited by-同舟云学术

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Published:2020-05-26 Issue:8 Volume:39 Page:763-770
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Platt Heather L.,Greenberg David,Tapiero Bruce,Clifford Robert A.,Klein Nicola P.,Hurley David C.,Shekar Tulin,Li Jianing,Hurtado Kim,Su Shu-Chih,Nolan Katrina M.,Acosta Camilo J.,McFetridge Richard D.,Bickham Kara,Musey Luwy K.,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

Reference37 articles.

1. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era.;Robinson;JAMA,2001

2. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.;Pilishvili;J Infect Dis,2010

3. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15.;Wahl;Lancet Glob Health,2018

4. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.;O’Brien;Lancet,2009

5. Healthcare utilization and cost of pneumococcal disease in the United States.;Huang;Vaccine,2011

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis;Health Technology Assessment;2024-07

2. Incidence of pneumococcal disease in children ≤48 months old in the United States: 1998–2019;Vaccine;2024-04

3. PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children;Expert Review of Vaccines;2023-12-20

4. Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children;Expert Review of Vaccines;2023-12-14

5. Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three Studies;Pediatric Infectious Disease Journal;2023-08-10